| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |